ANTHONY C HOOPER Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for ANTHONY C HOOPER.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of ANTHONY C HOOPER. ANTHONY C HOOPER is EVP, Global Commercial Ops. in AMGEN INC ($AMGN) and President US Pharmaceuticals in BRISTOL MYERS SQUIBB CO ($BMY) and Director in MANNKIND CORP ($MNKD) and Director in BeiGene, Ltd. ($BGNE).

Over the past year ANTHONY C HOOPER has been an insider in 2 companies. The total value of shares held by ANTHONY C HOOPER in these companies amounts to $64,363.

ANTHONY C HOOPER EVP, Global Commercial Ops.
AMGEN INC
Director
BeiGene, Ltd.
President US Pharmaceuticals
BRISTOL MYERS SQUIBB CO
Director
MANNKIND CORP
$ 64363 The total value of shares held by ANTHONY C HOOPER
Insider Rank

ANTHONY C HOOPER ranks 31,810 out of 350,000 insiders. Go to Insider Ranking to see more.

Latest Insider Trading Transactions of ANTHONY C HOOPER

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000111
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Sentiment: All, AMGN, BGNE, BMY, MNKD

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 19 2020BGNEBeiGene, Ltd.HOOPER ANTHONY CDirectorOption ExerciseA13.4245,383609,04045,383
May 26 2020MNKDMANNKIND CORPHOOPER ANTHONY CDirectorOption ExerciseA0.0038,760038,760
May 26 2020MNKDMANNKIND CORPHOOPER ANTHONY CDirectorOption ExerciseA0.0088,235088,235
Mar 06 2020BGNEBeiGene, Ltd.HOOPER ANTHONY CDirectorOption ExerciseA12.2221,970268,47321,970
Mar 04 2020MNKDMANNKIND CORPHOOPER ANTHONY CDirectorGrantA0.0030,0480126,20196.2 K to 126.2 K (+31.25 %)
May 07 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF169.43883149,607215,147216 K to 215.1 K (-0.41 %)
May 01 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Option ExerciseA177.4634,7026,158,21734,702
May 01 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.004,5080216,030211.5 K to 216 K (+2.13 %)
Mar 27 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF176.088,8071,550,737211,522220.3 K to 211.5 K (-4.00 %)
Mar 09 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.0017,6380220,121202.5 K to 220.1 K (+8.71 %)
Feb 01 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF191.27651124,517202,483203.1 K to 202.5 K (-0.32 %)
Feb 01 2018AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF198.00575113,850203,134203.7 K to 203.1 K (-0.28 %)
May 03 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Option ExerciseA162.6043,5727,084,80743,572
May 03 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.004,9200203,402198.5 K to 203.4 K (+2.48 %)
Mar 28 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF166.0412,1282,013,733198,482210.6 K to 198.5 K (-5.76 %)
Mar 09 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.0023,0920210,397187.3 K to 210.4 K (+12.33 %)
Feb 02 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF154.43668103,159187,305188 K to 187.3 K (-0.36 %)
Jan 31 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF157.1659893,982187,973188.6 K to 188 K (-0.32 %)
Jan 31 2017AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF157.161,053165,489188,571189.6 K to 188.6 K (-0.56 %)
May 05 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Option ExerciseA156.3543,5576,810,13743,557
May 05 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.005,1160189,312184.2 K to 189.3 K (+2.78 %)
Apr 29 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF162.851,659270,168184,196185.9 K to 184.2 K (-0.89 %)
Mar 29 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF149.2423,7853,549,673185,855209.6 K to 185.9 K (-11.35 %)
Mar 04 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.0045,2680209,230164 K to 209.2 K (+27.61 %)
Feb 01 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF152.7365199,427163,962164.6 K to 164 K (-0.40 %)
Feb 01 2016AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF150.47995149,718164,339165.3 K to 164.3 K (-0.60 %)
Apr 28 2015AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF167.911,575264,458165,334166.9 K to 165.3 K (-0.94 %)
Mar 31 2015AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF160.5528,6244,595,583166,909195.5 K to 166.9 K (-14.64 %)
Mar 13 2015AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF153.5827,5404,229,593195,148222.7 K to 195.1 K (-12.37 %)
Mar 06 2015AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...GrantA0.00107,3540222,688115.3 K to 222.7 K (+93.08 %)
Mar 03 2015AMGNAMGEN INCHOOPER ANTHONY CEVP, Global Commerc ...Payment of ExerciseF157.723,215507,070115,334118.5 K to 115.3 K (-2.71 %)
Mar 06 2008BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseA0.0013,077013,077
Mar 06 2008BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseA22.14171,4953,796,899171,495
Mar 04 2008BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF22.611,17826,635102,331103.5 K to 102.3 K (-1.14 %)
Mar 04 2008BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF22.611,03823,469103,509104.5 K to 103.5 K (-0.99 %)
Sep 12 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF0.003,8710104,558108.4 K to 104.6 K (-3.57 %)
Jun 21 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF31.232,43175,92095,54998 K to 95.5 K (-2.48 %)
Jun 01 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseM28.9030,000867,0000
Jun 01 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF30.1244313,34397,98098.4 K to 98 K (-0.45 %)
Jun 01 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF30.1228,785867,00498,423127.2 K to 98.4 K (-22.63 %)
Jun 01 2007BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...BuyM28.9030,000867,000127,20897.2 K to 127.2 K (+30.86 %)
Jun 22 2006BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF25.482,43161,942113,165115.6 K to 113.2 K (-2.10 %)
Mar 09 2006BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseA22.7378,7501,789,98878,750
Mar 09 2006BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF22.731,86242,323115,596117.5 K to 115.6 K (-1.59 %)
Mar 09 2006BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...GrantA22.735,107116,082117,458112.4 K to 117.5 K (+4.55 %)
Mar 09 2006BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...GrantA22.7318,900429,597112,35193.5 K to 112.4 K (+20.22 %)
Jul 12 2005BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF24.8263915,86068,45169.1 K to 68.5 K (-0.92 %)
Sep 21 2005BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...GrantA0.0025,000093,45168.5 K to 93.5 K (+36.52 %)
Jun 22 2005BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF0.002,430069,09071.5 K to 69.1 K (-3.40 %)
Mar 03 2005BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseA25.4555,8331,420,95055,833
Mar 03 2005BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...GrantA0.009,306071,52062.2 K to 71.5 K (+14.96 %)
Jul 12 2004BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Payment of ExerciseF24.1958714,20062,21462.8 K to 62.2 K (-0.93 %)
Mar 04 2004BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...Option ExerciseA28.1163,3331,780,29163,333
Mar 04 2004BMYBRISTOL MYERS SQUI ...HOOPER ANTHONY CPresident US Pharma ...GrantA0.0010,556062,80152.2 K to 62.8 K (+20.20 %)

Page:   1